The common things for fund are deals in the range of 10 - 50 millions dollars. The important activity for fund was in 2000. Opposing the other organizations, this New Medical Technologies works on 21 percentage points more the average amount of lead investments. The top amount of exits for fund were in 2018. The real fund results show that this VC is 0 percentage points less often commits exit comparing to other companies. The fund is generally included in less than 2 deals every year.
Among the various public portfolio startups of the fund, we may underline Cytos, Thommen Medical, Arpida AG The fund has exact preference in some founders of portfolio startups. Among the most successful fund investment fields, there are Medical Device, Manufacturing. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the New Medical Technologies, startups are often financed by Venrock, Techno Venture Management, Skyline Ventures. The meaningful sponsors for the fund in investment in the same round are HealthCap, Aventic Partners AG, Alta Berkeley Venture Partners. In the next rounds fund is usually obtained by Credit Suisse First Boston, HealthCap, HBM Healthcare Investments AG.
Related Funds
| Fund Name | Location |
| Applebee's | California, Glendale, United States |
| BDC | County Dublin, Dublin, Ireland |
| Brava Investments | New York, New York, United States |
| BVGroup | Bern, Gümligen, Switzerland |
| CR-CP Life Science Fund | China, Hong Kong, Hong Kong Island |
| Danfeng Venture Capital | China, Shanghai |
| Dodi Ventures | - |
| Figure Eight Investments | Boulder, Colorado, United States |
| HU Investments | Montclair, New Jersey, United States |
| InvestAmerican Investment Advisors | Minneapolis, Minnesota, United States |
| Lunova | Luleå, Norrbottens Lan, Sweden |
| Moody's Investors Service | New York, New York, United States |
| MTech Capital | California, Santa Monica, United States |
| National Express Group | Birmingham, England, United Kingdom |
| Renjing Yatang Cultural Communication | Beijing, Beijing, China |
| Ripple | California, San Francisco, United States |
| Srijan Capital | Bangalore, India, Karnataka |
| Startup Reykjavik | Gullbringusysla, Iceland, Reykjavík |
| Weekapaug Partners | Baltimore, Maryland, United States |
| Zhang Shi Touzi | China, Zhejiang, Zhuji |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
| 03 May 2002 | Solothurn, Switzerland | ||||
| $6M | 14 Dec 2001 | Solothurn, Switzerland | |||
Arpida AG | $43M | 23 Oct 2000 | Aargau, Switzerland | ||
Ingenium Pharmaceuticals AG | $59M | 01 Oct 2000 | Germany, Bavaria, Germany | ||
Cytos | $32M | 26 Jul 2000 | Zurich, Switzerland | ||
Viron Therapeutics | $7M | 19 Jan 2000 | London, England, United Kingdom | ||
Sunesis Pharmaceuticals | $25M | 06 Dec 1999 | South San Francisco, California, United States | ||
Cytokinetics, Inc. | $20M | 12 Oct 1999 | South San Francisco, California, United States | ||
Arpida AG | $16M | 01 Jul 1998 | Aargau, Switzerland |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
| 03 May 2002 | Solothurn, Switzerland | ||||
| $6M | 14 Dec 2001 | Solothurn, Switzerland | |||
Arpida AG | $43M | 23 Oct 2000 | Aargau, Switzerland | ||
Ingenium Pharmaceuticals AG | $59M | 01 Oct 2000 | Germany, Bavaria, Germany | ||
Cytos | $32M | 26 Jul 2000 | Zurich, Switzerland | ||
Viron Therapeutics | $7M | 19 Jan 2000 | London, England, United Kingdom | ||
Sunesis Pharmaceuticals | $25M | 06 Dec 1999 | South San Francisco, California, United States | ||
Cytokinetics, Inc. | $20M | 12 Oct 1999 | South San Francisco, California, United States | ||
Arpida AG | $16M | 01 Jul 1998 | Aargau, Switzerland |
